These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21541816)
1. MALDI tissue imaging: from biomarker discovery to clinical applications. Cazares LH; Troyer DA; Wang B; Drake RR; Semmes OJ Anal Bioanal Chem; 2011 Jul; 401(1):17-27. PubMed ID: 21541816 [TBL] [Abstract][Full Text] [Related]
2. Matrix-assisted laser desorption/ionization imaging mass spectrometry. Zaima N; Hayasaka T; Goto-Inoue N; Setou M Int J Mol Sci; 2010; 11(12):5040-55. PubMed ID: 21614190 [TBL] [Abstract][Full Text] [Related]
3. MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis. Gustafsson JO; Oehler MK; Ruszkiewicz A; McColl SR; Hoffmann P Int J Mol Sci; 2011 Jan; 12(1):773-94. PubMed ID: 21340013 [TBL] [Abstract][Full Text] [Related]
4. Matrix-assisted laser desorption/ionization and nanoparticle-based imaging mass spectrometry for small metabolites: a practical protocol. Sugiura Y; Setou M Methods Mol Biol; 2010; 656():173-95. PubMed ID: 20680591 [TBL] [Abstract][Full Text] [Related]
5. Current frontiers in clinical research application of MALDI imaging mass spectrometry. Neubert P; Walch A Expert Rev Proteomics; 2013 Jun; 10(3):259-73. PubMed ID: 23777216 [TBL] [Abstract][Full Text] [Related]
6. The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer. Goto T; Terada N; Inoue T; Nakayama K; Okada Y; Yoshikawa T; Miyazaki Y; Uegaki M; Sumiyoshi S; Kobayashi T; Kamba T; Yoshimura K; Ogawa O PLoS One; 2014; 9(2):e90242. PubMed ID: 24587297 [TBL] [Abstract][Full Text] [Related]
7. MALDI mass spectrometry in prostate cancer biomarker discovery. Flatley B; Malone P; Cramer R Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156 [TBL] [Abstract][Full Text] [Related]
8. Matrix-assisted laser desorption/ionization imaging mass spectrometry: a promising technique for reproductive research. Lagarrigue M; Lavigne R; Guével B; Com E; Chaurand P; Pineau C Biol Reprod; 2012 Mar; 86(3):74. PubMed ID: 22156474 [TBL] [Abstract][Full Text] [Related]
9. MALDI IMS and Cancer Tissue Microarrays. Casadonte R; Longuespée R; Kriegsmann J; Kriegsmann M Adv Cancer Res; 2017; 134():173-200. PubMed ID: 28110650 [TBL] [Abstract][Full Text] [Related]
10. MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (review). Kriegsmann J; Kriegsmann M; Casadonte R Int J Oncol; 2015 Mar; 46(3):893-906. PubMed ID: 25482502 [TBL] [Abstract][Full Text] [Related]
11. Tutorial: multivariate statistical treatment of imaging data for clinical biomarker discovery. Deininger SO; Becker M; Suckau D Methods Mol Biol; 2010; 656():385-403. PubMed ID: 20680603 [TBL] [Abstract][Full Text] [Related]
12. Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data. Panderi I; Yakirevich E; Papagerakis S; Noble L; Lombardo K; Pantazatos D Rapid Commun Mass Spectrom; 2017 Jan; 31(2):160-170. PubMed ID: 27791282 [TBL] [Abstract][Full Text] [Related]
13. MALDI imaging mass spectrometry - From bench to bedside. Schwamborn K; Kriegsmann M; Weichert W Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):776-783. PubMed ID: 27810414 [TBL] [Abstract][Full Text] [Related]
14. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Cazares LH; Troyer D; Mendrinos S; Lance RA; Nyalwidhe JO; Beydoun HA; Clements MA; Drake RR; Semmes OJ Clin Cancer Res; 2009 Sep; 15(17):5541-51. PubMed ID: 19690195 [TBL] [Abstract][Full Text] [Related]